Status:
COMPLETED
Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
Lead Sponsor:
AstraZeneca
Conditions:
Glycemia
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
This study will address the proportion of achievement patients in treatment target goal on glycemic control, hypertension and hyperlipidemia according to ADA 2008 guideline, among outpatients coming t...
Eligibility Criteria
Inclusion
- Patients who had been diagnosed with type II diabetes mellitus
- Patients with hypertension and / or hyperlipidemia
- Patients who had agreed to Informed
Exclusion
- Patients who had been diagnosed with type I diabetes mellitus
- Patients with neither hypertension and hyperlipidemia
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
4045 Patients enrolled
Trial Details
Trial ID
NCT00891124
Start Date
May 1 2009
End Date
October 1 2009
Last Update
November 3 2009
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Busan, South Korea
2
Research Site
Cheiju, South Korea
3
Research SIte
Daegu, South Korea
4
Research Site
Gwangju, South Korea